The gene coding for human interleukin-5 was synthesized and expressed in Escherichia coli under control of a heatinducible promoter. High-level expression, 10-15% of total cellular protein, was achieved in E. coli. The protein was produced in an insoluble state. A simple extraction, renaturation and purification scheme is described. The recombinant protein was found to be a homodimer, similar to the natural murine-derived protein. Despite the lack of glycosylation, high specific activities were obtained in three 'in vitro' biological assays. Physical characterization of the protein showed it to be mostly ca-helical, supporting the hypothesis that a conformational similarity exists among certain cytokines.
INTRODUCTION
Interleukin-5 (IL-5) is a specific haematopoietic growth factor responsible for eosinophil differentiation. Murine IL-5 has also been shown to have B-cell-growth-factor [1] and T-cell-replacingfactor activities [2] . These activities were originally thought to be derived from separate proteins, namely eosinophil differentiating factor (EDF), B-cell growth factor (BCGF-II) and T-cell replacing factor (TRF). The availability of recombinant-derived murine protein showed that these activities were derived from a single protein, namely IL-5.
Natural IL-5 has been isolated only from murine T-cell supernatants and shown to be a glycoprotein which exists as a homodimer (Mr 45 000) [2, 3] . The cDNA sequence of the murine species predicts an Mr of 13 000 for the polypeptide monomer [5] .
Human IL-5 cDNA [5] and genomic [6] genes have been cloned using the murine IL-5 cDNA [4] as a probe. The murine and human proteins show 70 % sequence similarity and have species cross-reactivity in EDF activity. The natural hIL-5 has not been purified and characterized, but recombinant hIL-5 has been expressed in several eukaryotic systems [7, 8] and shown to be a glycosylated, disulphide-linked homodimer of Mr 40000-50000.
Although hIL-5 has BCGF activity on murine B-lymphocytic cell lines and on selected human B-CLL cells [8] , this activity has not been detected using human BCGF bioassays [9] . The presence of mRNA coding for hIL-5 has been detected in a human T-cell clone [10] , the supernatant of which was shown to have EDF activity. Recently, human T-cell clones have been shown to have IL-5 activity which is blocked with an anti-IL-5 monoclonal antibody [11] . In order to obtain the human protein in relatively large amounts to investigate further its biological properties and perform physicochemical and structural studies, we have produced the recombinant protein in Escherichia coli. The present study describes the expression, isolation and characterization of recombinant hIL-5.
MATERIALS AND METHODS

Reagents
Polynucleotide kinase was kindly given by Dr. N. Murray, (Department of Molecular Biology, University of Edinburgh, Edinburgh, Scotland, U.K.). All other enzymes were purchased from New England Biolabs (Beverly, MA, U.S.A.). Protein standards for gel filtration and for electrofocusing, DEAESepharose, Sephacryl S-200 and Sephadex G-25 resins were from Pharmacia (Uppsala, Sweden). Ultrogel AcA54 was from IBF Biotechnics (Villeneuve-La-Garenne, France).
Buffer compositions
The buffers used for the extraction of hIL-5 were as follows:
Buffer A, 
Protein purification
All steps were carried out at 0-4 'C, except where stated, hIL-5 was monitored in all steps by SDS/PAGE. E. coli cells (50 g wet wt.) were suspended in 200 ml of buffer A and broken by two passages through an Amicon French pressure cell (Kontron, Basel, Switzerland). To reduce the viscosity, the suspension was sonicated for 30 s after each passage. The solution was centrifuged at 10000 g for 30 min and the pellet washed by suspension and re-centrifugation once with 100 ml of Buffer B and once with 100 ml of Buffer C. The final washed pellet was suspended in 500 ml of Buffer D and stirred overnight at 4 "C. The suspension was centrifuged at 100000 g for 30 min. The conductivity of the clarified supernatant was adjusted to 1.2 mS cm-1 by dilution with deionized 8 The flow-through fractions containing hIL-5 were pooled and concentrated by ultrafiltration on an Amicon YM5 filter to 100 ml. Solid (NH4)2S04 was added to 25 % saturation, the precipitate collected by centrifugation, dissolved in 30 ml of Buffer E, and heated for 1 h at 60 'C. After cooling to room temperature, the solution was applied to a Sephacryl S-200 column (4.4 [15] . Urea gradients (0-9 M) were buffered with 0.05 M-glycine/NaOH, pH 9.0. Electrophoresis was performed at 30 mA for 16 h at 20 'C. Electrofocusing and pH-titration-curve analysis (combined electrofocusing and electrophoresis) were performed on the PHAST System according to manufacturer's instructions.
C.d. measurements
Spectra were recorded on a Jasco J-600 spectropolarimeter.
The mean residue molecular mass was calculated as 114.5. All solutions were filtered with a 0.22-,um-pore-size filter (Millipore) before use.
Protein determination
Concentrations of purified protein were determined by u.v. absorbance using a calculated value for A0 C1m of 0.66 at 280 nm. Protein concentrations in crude extracts were determined as described by Bradford [16] . Relative amounts of hIL-5 present at each stage of purification were determined by densitometric scanning of Coomassie Blue-stained SDS/PAGE gels.
Analytical ultracentrifugation
Protein (0.45 mg/ml) was dialysed against 50 mM-Tris/HCl, pH 7.5, containing 1 % (w/v) KCI. Measurements were made using a Beckman LB-70 preparative ultracentrifuge equipped with a Prep UV Scanner. For sedimentation-equilibrium measurements, the centrifuge was operated at 15000 rev./min at 20 'C. Measurements were taken after 15 h and a baseline established by centrifugation at 45000 rev./min for 3 h. Sedimentation-velocity measurements were made at 40000 rev./min at 20 'C and were recorded every 10 min for 90 min. Molecular masses and sedimentation coefficients were calculated from the least-squares fits of plots of lnA280 versus r2 and ln r versus t respectively.
Reduction and alkylation
Protein, dissolved in 0.1 M-Tris/HCl, pH 8.6 (1-2 mg/ml), containing 1 mM-EDTA and 4 M-Gdm* HCI, was purged with N2'
DTT was added to 10 mm, and the solution was incubated for 15 min at 37 'C. lodoacetamide (50 mM) was added, followed by incubation in the dark for 30 min at 37 'C. Thiol and disulphide analysis Thiol groups were measured using 5,5'-dithiobis-(2-nitrobenzoic acid) as previously described [18] .
Biological activity
The BCGF assay utilizes a mouse pre-B-cell line, LyH7.B13, which responds to murine IL-3 and hIL-5 [19] , kindly provided by Dr Eosinophil differentiation was assayed on both mouse and human bone marrow. The mouse bone-marrow assay was performed as described by Strath et al. [20] . Differentiation was estimated indirectly by measuring peroxidase activity after 5 days of culture. The assay with human bone marrow was performed as described by Clutterbuck & Sanderson [21] . Differentiation after 21 days of culture was measured directly by counting the number of eosinophils after staining with Luxol Fast Blue.
Analytical chromatography
The Pharmacia f.p.l.c. system was used. Anion-exchange chromatography was performed with 1 mg of protein, using a MonoQ 5/5 column (Pharmacia). The column was equilibrated with 20 mM-Tris/HCl, pH 7.0. Bound protein was eluted with a gradient of 0-0.5 M-NaCl.
Chromatofocusing was with a MonoP 5/20 column (Pharmacia). pH gradients of 3-9 and 6.5-4.5 were generated according to the manufacturer's instructions. The overall recovery of protein was about 0.72 mg of hIL-5/g wet wt. of cells, which represents a final yield of about 6.5 %. The purification is summarized in Table 1 , and the SDS/ polyacrylamide gel shown in Fig. 1 (lanes a-e) indicates the purity of the protein at various stages. (Fig. 1, lane e) , which is close to the value of 12291 predicted from the cDNA sequence [8] . Analysis of the protein under non-reducing conditions gave a single bond of Mr of 27000 (Fig. 1, lane f) , indicating that the protein is a disulphide-linked dimer. The Mr of the protein under native conditions was measured by sedimentation equilibrium. An Mr of 24000 was determined, indicating that hIL-5 is a homodimer under native conditions. This result was confirmed by gel filtration, where a single symmetrical peak was observed corresponding to an Mr of about 27000.
RESULTS
Physical homogeneity of the hIL-5 preparation was indicated by a single boundary during sedimentation-velocity analysis (s20, 2.5S) and by the linearity of the plot of protein distribution at sedimentation equilibrium.
Natural glycosylated murine IL-5 [2, 3] and glycosylated recombinant human and murine IL-5 species produced in mammalian cells [7, 8] 8-29) may provide the dimerization interface for the protein, the dimer being further stabilized by the two intermolecular disulphide bonds.
Amino acid composition and sequence analysis The amino acid composition was close to that predicted from the cDNA sequence (Table 1 ). The first cycle of N-terminal sequencing indicated that the protein retained methionine derived from initiating N-formylmethionine. Further sequencing (20 cycles) confirmed the sequence predicted for the first 20 residues of the mature protein [8] .
The sequence of the C-terminal region was confirmed by m.s. of protein digested with CNBr [17] . The major peak obtained after h.p.l.c. gave a signal at m/z = 991.4, corresponding to the peptide NTEWIIES (theoretical m/z = 991.0), as expected for the C-terminal peptide resulting from cleavage at Met-105.
Charge heterogeneity
Major species of pl values 5.9 and 5.6 and minor species of pl 6.4 and 5.4 were observed after electrofocusing (results not shown). Titration-curve analysis indicated that the charge differences were probably due to deamidation (results not shown). Separation of the various charge isomers was achieved by either chromatofocusing or anion-exchange chromatography at pH 7.0. All the separated species had similar specific biological activities, similar to that for unfractionated protein (see below).
Conformational analysis; c.d. and urea-gradient electrophoresis
The far-u.v. dichroic spectrum (Fig. 2a) indicated two minima at 207 nm and 221 nm, typical of proteins with substantial ahelical content. Analysis of the spectrum by the Contrin method [23] and by the method of Chang et al. [24] indicated 76% helix/24 % remainder and 60% helix/40 % remainder respectively. The protein thus appears to be mostly a-helical, with little or no contribution by f-sheet to the overall secondary structure. Similar results have been reported for the cytokine interleukin-2 (IL-2), which contains no ,-sheet structure [25] . [Urea] Fig. 3 . Urea-gradient electrophoresis of hIL-5
The buffer for electrophoresis and sample application was 50 mMglycine/NaOH, pH 9.0. Electrophoresis in the direction indicated was towards the anode.
It has been suggested that hIL-5 contains a four-a-helical motif [26] , similar to that determined for IL-2 by X-ray crystallography [27] . This motif has been proposed for other cytokines as well, suggesting a conformational similarity between them [26] . The a-helical content estimated here for hIL-5 is certainly consistent with this type of structure.
The near-u.v. c.d. spectrum (Fig. 2b) shows weak negative ellipticity, with several minima in the region 260-280 nm, presumably due to contributions from tyrosine residues. The nearu.v. c.d. signal was lost upon treating the protein with 4 MGdm -HCI, indicating protein unfolding.
Urea-gradient electrophoresis also supports the view that the hIL-5 preparation has a native-like conformation. A single unfolding transition was observed at about 5 M-urea (Fig. 3) , typical of proteins with high rates of folding and refolding relative to the rate of electrophoresis [15] . Although only one transition zone was observed, several distinct bands were observed in the region of the gel corresponding to native protein (0-5 M-urea). These various species, not clearly resolved in unfolded protein, most likely correspond to the charge isomers observed upon electrofocusing analysis (see above). The charge differences did not affect the thermodynamic stability of the protein and, as mentioned above, did not affect biological activity.
Biological activity
The specific activities using the B-13, murine EDF and human EDF assays were 0.75 x 107 (±0.085, n = 5), 1.1 x 107 and 2.5 x 107 units/mg respectively. The EDF assay value is similar to that reported for recombinant hIL-5 derived from yeast [8] .
Glycosylation is clearly not essential for either biological activity or subunit assembly of the protein.
